vs
Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $4.9M, roughly 1.5× Sensus Healthcare, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -64.1%, a 56.6% gap on every dollar of revenue. On growth, Marygold Companies, Inc. posted the faster year-over-year revenue change (-4.5% vs -62.2%). Over the past eight quarters, Marygold Companies, Inc.'s revenue compounded faster (-1.5% CAGR vs -31.9%).
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
MGLD vs SRTS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.6M | $4.9M |
| Net Profit | $-576.0K | $-3.2M |
| Gross Margin | 74.0% | 38.4% |
| Operating Margin | -8.3% | -63.8% |
| Net Margin | -7.5% | -64.1% |
| Revenue YoY | -4.5% | -62.2% |
| Net Profit YoY | 67.0% | -304.9% |
| EPS (diluted) | $-0.01 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.6M | $4.9M | ||
| Q3 25 | $7.0M | $6.9M | ||
| Q2 25 | $7.2M | $7.3M | ||
| Q1 25 | $7.0M | $8.3M | ||
| Q4 24 | $8.0M | $13.1M | ||
| Q3 24 | $7.9M | $8.8M | ||
| Q2 24 | $8.3M | $9.2M | ||
| Q1 24 | $7.9M | $10.7M |
| Q4 25 | $-576.0K | $-3.2M | ||
| Q3 25 | $-356.0K | $-943.0K | ||
| Q2 25 | $-1.5M | $-1.0M | ||
| Q1 25 | $-1.0M | $-2.6M | ||
| Q4 24 | $-1.7M | $1.5M | ||
| Q3 24 | $-1.6M | $1.2M | ||
| Q2 24 | $-1.9M | $1.6M | ||
| Q1 24 | $-529.0K | $2.3M |
| Q4 25 | 74.0% | 38.4% | ||
| Q3 25 | 77.0% | 39.4% | ||
| Q2 25 | 67.8% | 39.7% | ||
| Q1 25 | 75.0% | 52.2% | ||
| Q4 24 | 74.1% | 54.4% | ||
| Q3 24 | 73.1% | 59.3% | ||
| Q2 24 | 72.5% | 58.7% | ||
| Q1 24 | 70.5% | 62.5% |
| Q4 25 | -8.3% | -63.8% | ||
| Q3 25 | -18.2% | -37.3% | ||
| Q2 25 | -16.5% | -26.6% | ||
| Q1 25 | -21.4% | -31.7% | ||
| Q4 24 | -22.8% | 13.2% | ||
| Q3 24 | -27.4% | 16.9% | ||
| Q2 24 | -33.3% | 21.5% | ||
| Q1 24 | -18.7% | 27.1% |
| Q4 25 | -7.5% | -64.1% | ||
| Q3 25 | -5.1% | -13.7% | ||
| Q2 25 | -20.4% | -14.2% | ||
| Q1 25 | -14.4% | -30.8% | ||
| Q4 24 | -21.8% | 11.8% | ||
| Q3 24 | -20.1% | 13.7% | ||
| Q2 24 | -22.5% | 17.4% | ||
| Q1 24 | -6.7% | 21.3% |
| Q4 25 | $-0.01 | $-0.19 | ||
| Q3 25 | $-0.01 | $-0.06 | ||
| Q2 25 | $-0.04 | $-0.06 | ||
| Q1 25 | $-0.02 | $-0.16 | ||
| Q4 24 | $-0.04 | $0.10 | ||
| Q3 24 | $-0.04 | $0.07 | ||
| Q2 24 | $-0.05 | $0.10 | ||
| Q1 24 | $-0.01 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $22.7M | $48.1M |
| Total Assets | $27.8M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $22.1M | ||
| Q3 25 | $12.5M | $24.5M | ||
| Q2 25 | $12.8M | $22.2M | ||
| Q1 25 | $15.6M | $19.1M | ||
| Q4 24 | $14.9M | $22.1M | ||
| Q3 24 | $17.5M | $22.6M | ||
| Q2 24 | $15.0M | $19.0M | ||
| Q1 24 | $16.1M | $14.7M |
| Q4 25 | $22.7M | $48.1M | ||
| Q3 25 | $22.9M | $51.2M | ||
| Q2 25 | $23.0M | $52.1M | ||
| Q1 25 | $24.3M | $53.0M | ||
| Q4 24 | $23.4M | $55.8M | ||
| Q3 24 | $25.5M | $54.1M | ||
| Q2 24 | $26.6M | $52.9M | ||
| Q1 24 | $28.4M | $51.2M |
| Q4 25 | $27.8M | $53.0M | ||
| Q3 25 | $28.4M | $58.3M | ||
| Q2 25 | $30.4M | $58.9M | ||
| Q1 25 | $33.5M | $60.2M | ||
| Q4 24 | $33.0M | $62.2M | ||
| Q3 24 | $35.9M | $59.9M | ||
| Q2 24 | $32.9M | $58.2M | ||
| Q1 24 | $33.7M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-908.0K | $-2.2M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -47.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-908.0K | $-2.2M | ||
| Q3 25 | $-533.0K | $2.3M | ||
| Q2 25 | $-3.3M | $3.1M | ||
| Q1 25 | $-1.2M | $-2.7M | ||
| Q4 24 | $-770.0K | $-827.0K | ||
| Q3 24 | $-893.0K | $4.0M | ||
| Q2 24 | $-1.9M | $4.2M | ||
| Q1 24 | $-658.0K | $-8.2M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | $-562.0K | $2.3M | ||
| Q2 25 | $-3.4M | $3.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | $-776.0K | $-1.1M | ||
| Q3 24 | $-940.0K | $3.6M | ||
| Q2 24 | $-2.0M | $4.2M | ||
| Q1 24 | — | $-8.4M |
| Q4 25 | — | -47.9% | ||
| Q3 25 | -8.1% | 33.3% | ||
| Q2 25 | -46.8% | 42.2% | ||
| Q1 25 | — | -32.2% | ||
| Q4 24 | -9.7% | -8.6% | ||
| Q3 24 | -11.9% | 40.9% | ||
| Q2 24 | -23.8% | 45.8% | ||
| Q1 24 | — | -79.0% |
| Q4 25 | 0.0% | 3.2% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.7% | 0.4% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.6% | 3.8% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.0% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
